COVID-19 Return to Work Plan: Antibody Testing and Temperature Screening

Return-to-Work Plans | DOT Compliance | CNS

What is your company’s Return to Work Plan?

As stay at home orders are being lifted across the country and employees start trickling back into the office or plants, it would be wrong to assume things will return to normal.

It is imperative that business owners take responsibility for protecting their employees and this can be accomplished by developing a Return to Work Plan for their organization.

In hotspots like New York, many are convinced they have already been exposed to and contracted COVID-19. However, the worse thing a person could do is assume they are immune because they believe that fever back in January was COVID-19.

This type of mentality makes a Return to Work Plan even more important.

What is a Return to Work Plan?

Basically, it means that businesses need to create a process and an environment that makes it safe for their employees to return to work.

Each Return to Work Plan will of course be unique to the company, but there are many similar concepts that can be implemented, including:

  • Antibody Testing
  • Pre-shift Temperature Screenings
  • How often will employees be checked?
  • Will employees return on a gradual basis?
  • Are there plans for cleaning of work areas?
  • Are there plans for keeping employees at a distanced?
  • Will face masks be required?

There is a much longer list  of rules and procedures that business owners can follow, but our focus is on the two that will assist in determining if employees are safe to be at work, Antibody Testing and Pre-shift Temperature Screenings.

What is COVID-19 Antibody Testing?

The COVID-19 Antibody Test provides individuals insight into whether they have been exposed to coronavirus and developed antibodies. This could be invaluable information for your company and assist in many decisions related to those employees who have developed immunity.

According to the US Food and Drug Administration, COVID-19 antibody testing may indicate whether “the person has been exposed to the virus and developed antibodies against it, which may mean that person has at least some immunity to the coronavirus.”

However, it is important to note that the length of protection and whether the antibodies protect from re-infection is unknown at this point.

On May 7, a New York Times article detailed a new study that “adds evidence of immunity among those who have already been exposed to the disease, regardless of age, sex or severity of illness – making antibodies to the virus.” Experts were shocked by the percentage of people who have antibodies that were never diagnosed with coronavirus.

How is Antibody Testing useful for employers?

While the science on COVID-19 is evolving, testing for antibodies may help identify individuals who have likely been exposed. This information is helpful to make informed decisions about their risk of infection and spreading the virus in the workplace.

This is useful for employers as staff who are immune could replace vulnerable individuals, especially in high-transmission settings in the transportation industry, building a “shield immunity” in the population.

As of this writing, the Center for Health Security has provided a list of tests approved for research or individual use in the US that accurately detect antibodies in people who have them between 82 and 100 percent of the time. Their ability to correctly identify antibodies only in those who actually have them ranges from 91 to 100 percent.

It may take up to 14 days after the onset of symptoms for antibodies to be developed within the body and 91% of people develop such antibodies within the first 8-13 days. Some of those infected with COVID-19 will never exhibit symptoms, but will have a detectable antibody response.

Who is a candidate for Antibody Testing?

Antibody testing is not intended for use in individuals with an active COVID-19 infection, including individuals with symptoms. Patients who believe they may have COVID-19 are strongly encouraged to contact their healthcare provider.

All interested persons who have neither felt feverish in the last 3 days nor experienced any other COVID-19 symptoms within the past 10 days are appropriate candidates. Symptoms include:

  • loss of smell or taste
  • shortness of breath
  • dry cough
  • feeling weak or lethargic
  • lightheadedness or dizziness
  • vomiting or diarrhea
  • slurred speech
  • seizures

To protect collection site staff, please remember to wear either a face mask or some other form of face covering, when arriving at the laboratory collection site.

What are COVID-19 Pre-Shift Temperature Screenings?

Pre-Shift Temperature Screenings simply means that you will be screening each crew member and staff when they are reporting for duty, thereby reducing the risk to other employees.

If your employees have direct contact with someone who is ill or otherwise vulnerable populations, you want to know right away to prevent any spreading to other staff members.

Temperature screenings would be useful to continue using on all employees or those that have tested negative for antibodies.

Learn more about:
COVID-19 Services and Pre-shift Temperature Screenings


How can CNS help?

At CNS, we know how difficult it is as a business owner to determine what steps need to be taken, so we are assisting employers in getting their Return to Work Plans started by implementing our COVID-19 Antibody Tests and Pre-Shift Temperature Screenings.

Our Antibody test is a blood test identifying the presence of antibodies which indicate a person’s immune response to COVID-19. Positive results indicate that an individual may have had previous exposure to COVID-19 and their body has developed antibodies.

For more information, contact us at 888.260.9448 or info@cnsprotects.com.